DOJ investigating use of Semler Scientific’s QuantaFlo, STAT reports

The Department of Justice is investigating Semler Scientific (SMLR) for possible violations of a federal anti-fraud law related to its marketing of a product known as QuantaFlo, a test used in the diagnosis of peripheral artery disease by UnitedHealth Group (UNH) and other large insurers, STAT’s Lizzy Lawrence and Casey Ross report. Semler has recently disclosed that the government is investigating the use of QuantaFlo related to claims made for reimbursement from government health programs, which in some cases pay insurers more money to cover patients diagnosed with peripheral artery disease.